Understanding tumor complexity for better cancer treatment
Proteogenomic translator for cancer biomarker discovery towards precision medicine
['FUNDING_OTHER'] · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · NIH-11074108
This study is looking at how different changes in genes and proteins work together in tumors to help us find better, personalized treatments for cancer patients.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (nih funded) |
| Locations | 1 site (NEW YORK, UNITED STATES) |
| Trial ID | NIH-11074108 on ClinicalTrials.gov |
What this research studies
This research aims to enhance our understanding of the complex interactions within tumors by analyzing various molecular data types. It employs advanced computational techniques to identify how genetic changes affect protein functions and cancer characteristics. By integrating multiple types of biological data, the project seeks to uncover the regulatory networks that drive cancer phenotypes and immune responses. This comprehensive approach could lead to more precise cancer therapies tailored to individual patients.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with various types of cancer who are seeking innovative treatment options.
Not a fit: Patients with non-cancerous conditions or those not diagnosed with any form of cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the discovery of new cancer biomarkers and more effective personalized treatment strategies.
How similar studies have performed: Previous research has shown promise in using multi-omics approaches for cancer biomarker discovery, indicating that this methodology has potential for success.
Where this research is happening
NEW YORK, UNITED STATES
- ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI — NEW YORK, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: WANG, PEI — ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
- Study coordinator: WANG, PEI
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Anti-Cancer Agents, anti-cancer drug, anti-cancer therapy